Navigation Links
Omeros Names Dr. Patrick Gray as Scientific Fellow
Date:3/27/2012

SEATTLE, March 27, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced the appointment of Patrick W. Gray, Ph.D. to the position of scientific fellow.

"Pat has an impressive track record of identifying commercially successful programs and products early in their development cycle," said Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros.  "In his role as scientific fellow, Pat will be able to leverage his unique and deep expertise across our research and development matrix.  We are pleased that he has joined our senior management team, and we look forward to him contributing to our success."

"The scientific depth and commercial potential of Omeros' programs are remarkable," stated Patrick W. Gray, Ph.D., Omeros' scientific fellow.  "Omeros has a strong and experienced management team, and I look forward to helping the Company continue to transform its pipeline of programs into marketed products."

Dr. Gray brings to Omeros more than 30 years of experience in the biotechnology industry. He joined Omeros after serving from 2007 until 2012 as the chief scientific officer of Accelerator Corporation, a biotechnology-company investor and incubator affiliated with Amgen Ventures, ARCH Venture Partners, OVP Ventures Partners and the Institute for Systems Biology. Prior to Accelerator, Dr. Gray was the chief executive officer of nura, inc., a privately held biotechnology company acquired by Omeros in 2006. Before nura, he held senior scientific and management positions at Genentech, Inc., ICOS Corporation and MacroGenics, Inc.

Dr. Gray's career accomplishments include the first cloning and characterization of
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omeros to Present at the Cowen and Company 32nd Annual Health Care Conference
2. BioMed Realty and Omeros Sign New 64,500 Square Foot Lease in Seattle
3. Omeros Announces Submission to European Medicines Agency of Paediatric Investigation Plan Letter of Intent for OMS302
4. Omeros to Present at 23rd Annual Piper Jaffray Health Care Conference
5. Omeros Announces First Patients Treated in Phase 3 Clinical Program Evaluating OMS302
6. Omeros Unlocks Four Additional Orphan GPCRs
7. Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep Disorders
8. Omeros Reports Allowance of Additional Patent for Arthroscopic Product
9. Omeros Announces Clinical Development Programs for OMS103HP and OMS302
10. Omeros Corporation Reports First Quarter 2011 Financial Results
11. Omeros Announces Expansion of Potential Indications for PDE7 Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014  Today the US Surgeon General issued ... sun tanning or sun burns stating they can lead directly ... Boris Lushniak , says that "skin cancer is a ... too much exposure to indoor and outdoor ultraviolet light is ... Aesthetic Medicine, in Boca Raton, Florida , ...
(Date:7/30/2014)... BURLINGTON, Mass. , July 30, 2014 /PRNewswire/ ... United States preclinical animal research imaging ... trend toward multimodality imaging, such as combining computed ... and optical imaging. This demand stems from the ... publication requirements among scientific journals, which will spur ...
(Date:7/30/2014)... Cynosure, Inc. (NASDAQ: CYNO ), a ... minimally invasive applications, today announced that the Board of Directors ... Financial Officer Timothy W. Baker to President of ... to serve as CFO and will take the title of ... Chief Executive Officer. "Tim has been a ...
Breaking Medicine Technology:Indoor and Outdoor Sun Tanning or Sun Burns Directly Linked to Deadly Melanoma Skin Cancer 2Growing Popularity of Multimodality Imaging Will Drive the Preclinical Animal Research Imaging System Market 2Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2
... FDA, Favorable Scientific Advice from EMEA and Phase 3 Plans ... Cell Lung ... Dr. Giuseppe Giaccone,Chief of the Medical Oncology Branch at the ... Phase 2 trial with talactoferrin alfa in non-small cell,lung cancer ...
... End-User Satisfaction, ... of Care Improvements, ORLANDO, Fla., Feb. 25 ... Society (HIMSS) 2008 Annual,Conference and Exhibition in Orlando, ... faith-based healthcare system in Nebraska and southwestern,Iowa, announced ...
Cached Medicine Technology:Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting 2Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting 3Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting 4Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting 5Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting 6Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting 7Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing 2Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing 3Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing 4Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing 5
(Date:7/31/2014)... York City, NY (PRWEB) July 31, 2014 ... hot chocolate , will be available in New York's ... Company in August. BRC is known for their commitment ... the Associated Press. , Chocolatto® is the new sensation ... Italian hot chocolate ! A delicious highly popular Italian ...
(Date:7/31/2014)... Thanks to its mildly sweet flavor ... been used as a medium for delivery of ... However consistent, dependable sourcing of erythritol often fluctuates. ... and beverage manufacturers’ increasing needs for reliable, dependable, ... ErysweetTM Erythritol. , “Erysweet is unique in ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 The study, ... explores variation in Medicare episode of care payments for ... pneumonia, and major joint replacements (hips and knees). ... Medicare’s Bundled Payments for Care Improvement program, the study ... least expensive regions in the country. , “Our study ...
(Date:7/30/2014)... Vail and Beaver Creek, Colo., skiers have ... “Blind Skier.” Those skiers and guides are enjoying time ... , a non-profit organization founded in 2001 that matches ... for snow sport opportunities. Visually impaired skiers and snowboarders ... pick up an application to participate in the program ...
(Date:7/30/2014)... Calling all runners in the Richmond, VA region. , Tidewater ... monthly Runner’s Injury Clinic at the Glen Allen ... Monday of each month through the end of the year ... December 8. , The clinics run from 5:30 to ... and attire, will receive a complimentary evaluation of running injuries ...
Breaking Medicine News(10 mins):Health News:Dolce Vite Chocolatto® - World's Best Thick Dark Italian Hot Chocolate Now Available at NYC's Favorite Cafe Brooklyn Roasting Company 2Health News:Steviva Ingredients Launches Erysweet Erythritol 2Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 2Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 3Health News:Colorado Non-Profit Foresight Ski Guides Seeking Applications for Blind and Visually Impaired Skiers and Guides for Vail Ski Season 2Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 2Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 3
... CGCP), announced that the company will release,results for its ... prior,to market open on Tuesday, March 4, 2008. The ... Vice President and Chief Financial,Officer William R. Abbott will ... Eastern time (9:00 a.m. Pacific time) to review the ...
... new low-fat ice cream dipped in chocolate, OAKLAND, ... The Skinny Cow(R) brand urges dieters everywhere to release ... in at just 80 calories per pop, the perfectly-portioned,chocolate-dipped ... and refreshing mint flavors. Skinny Dippers contain no trans ...
... February 12 Aircraft Medical ("Aircraft"),announces that it ... validity of its European Patent No. 1307131 (the ... in the Edinburgh Court of,Session action will result ... has also lodged defences at the Court of ...
... seek any assistance, MORAGA, Calif., Feb. 12 ... disorders, it is regularly under diagnosed,by medical professionals, according ... million people affected every year., Most of us ... fatigue, or trembling -- before important events such as,exams, ...
... Medical Centers (BMC) New England Centenarian Study report ... subjects, avoiding age-related diseases (i.e. stroke, cardiovascular disease, ... longevity; rather, the avoidance of disability may be ... findings appear in the February 11th issue of ...
... Institute,s new CWC Program bridges the gap between fitness ... effort to reduce health care costs in America, ... a Certified Wellness Coach (CWC) program that bridges,the gap ... CWC provides a vast variety of learning objectives. ...
Cached Medicine News:Health News:Cardiogenesis Corporation to Report 2007 Fourth Quarter and Year-End Results on March 4th 2Health News:Dip Your Diet in Chocolate ... Introducing New Skinny Dippers! 2Health News:Aircraft Medical Files Counter Action Against Verathon 2Health News:40 Million Americans Endure Anxiety Everyday 2Health News:Researchers at BMC find disability does not necessarily follow disease in living to old age 2Health News:Spencer Institute Announces Wellness Coaching: Innovative Certification Training for Life Coaching 2
... Finnpipette BioControl multichannel has ... as the single channel ... fits allseven multichannel and ... cone modules. Both pipettes ...
... and best value in high performance electronic ... ultra lightweight design reduce hand fatigue and ... lever tip ejector , Color coding for ... or for greater performance use Hamilton AdvanTip ...
... pro Electronic Pipette is ideal for all ... easy-to-follow display, ergonomically-placed operating buttons, and various ... pipetting and diluting make this a lab ... of a manual pipette without any adverse ...
... The Research pro Electronic Pipette is ... the laboratory. Its easy-to-follow display, ergonomically-placed operating ... pipetting, dispensing, reverse pipetting and diluting make ... the simple functions of a manual pipette ...
Medicine Products: